Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological Risk.
hypofractionated
pattern of failure
prognosis
prostate cancer
radiotherapy
salvage therapy
second primary cancer
stereotactic body radiotherapy
survival
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
30 Sep 2022
30 Sep 2022
Historique:
received:
18
08
2022
revised:
22
09
2022
accepted:
27
09
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
A cohort of 650 patients treated for localized prostate cancer (PCa) with CyberKnife
Identifiants
pubmed: 36289708
pii: biomedicines10102446
doi: 10.3390/biomedicines10102446
pmc: PMC9598896
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):1-7
pubmed: 21470793
N Engl J Med. 2012 Jul 19;367(3):203-13
pubmed: 22808955
Radiother Oncol. 2014 Feb;110(2):213-28
pubmed: 24485765
Cancers (Basel). 2021 Feb 12;13(4):
pubmed: 33673077
Radiother Oncol. 2015 Nov;117(2):252-7
pubmed: 26409832
BJU Int. 2022 Apr;129(4):423-433
pubmed: 34171173
Radiother Oncol. 2005 Jul;76(1):1-3
pubmed: 15990189
World J Mens Health. 2022 Jul;40(3):368-379
pubmed: 34448375
JAMA. 2017 Jun 27;317(24):2532-2542
pubmed: 28655021
Eur Urol. 2021 Sep;80(3):280-292
pubmed: 33309278
Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):1095-101
pubmed: 10192361
J Clin Oncol. 2020 Sep 1;38(25):2830-2838
pubmed: 32484754
Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1588-97
pubmed: 18374232
BMJ. 2016 Mar 02;352:i851
pubmed: 26936410
Lancet. 2019 Aug 3;394(10196):385-395
pubmed: 31227373
Pol J Pathol. 2022;73(1):27-33
pubmed: 35848478
N Engl J Med. 2014 Mar 6;370(10):932-42
pubmed: 24597866
BJU Int. 2012 Dec;110(11):1696-701
pubmed: 22889401
Cancers (Basel). 2022 Mar 23;14(7):
pubmed: 35406385
Cancers (Basel). 2019 Sep 12;11(9):
pubmed: 31547436
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819870815
pubmed: 31462169
J Contemp Brachytherapy. 2021 Aug;13(4):365-372
pubmed: 34484350
Eur Urol. 2022 Jun 7;:
pubmed: 35688664
Cancers (Basel). 2022 Jan 12;14(2):
pubmed: 35053530
BJU Int. 2022 Sep;130(3):370-380
pubmed: 35373443
N Engl J Med. 2016 Oct 13;375(15):1425-1437
pubmed: 27626365
N Engl J Med. 2016 Oct 13;375(15):1415-1424
pubmed: 27626136
Radiol Med. 2021 Jul;126(7):989-997
pubmed: 33835309
Lancet Oncol. 2019 Nov;20(11):1531-1543
pubmed: 31540791
Eur Urol. 2021 Feb;79(2):243-262
pubmed: 33172724
Radiother Oncol. 2021 May;158:184-190
pubmed: 33639192
Lancet Oncol. 2021 Mar;22(3):402-410
pubmed: 33662287
Br J Radiol. 2016 Sep;89(1065):20150981
pubmed: 27384381
Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):1021-31
pubmed: 11429230
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):89-94
pubmed: 22652106
JAMA Netw Open. 2022 Jul 1;5(7):e2223025
pubmed: 35900763